• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一份针对帕金森病患者的简短社会心理调查问卷:SCOPA-PS。

A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS.

作者信息

Marinus Johan, Visser Martine, Martínez-Martín Pablo, van Hilten Jacobus J, Stiggelbout Anne M

机构信息

Department of Neurology, Leiden University Medical Center K5 Q 92, P.O. Box 9600, NL-2300 RC Leiden, The Netherlands.

出版信息

J Clin Epidemiol. 2003 Jan;56(1):61-7. doi: 10.1016/s0895-4356(02)00569-3.

DOI:10.1016/s0895-4356(02)00569-3
PMID:12589871
Abstract

The purpose of this study was to develop a short questionnaire for psychosocial functioning in patients with Parkinson's Disease (PD). The SCales for Outcomes in Parkinson's disease-PsychoSocial questionnaire (SCOPA-PS) was tested in a survey and compared with other instruments and with medical information. This survey was sent to 205 patents with idiopathic PD. Eighty-six percent of the questionnaires were returned. Cronbach's alpha was 0.83. Two-week test-retest reliability was 0.85 (intraclass correlation coefficient). Construct validity with other scales (Spearman's rho) was 0.82 for the Parkinson's Disease Questionnaire-39-item version (PDQ-39), 0.76 for the PDQ-8, 0.69 for the Hospital Anxiety and Depression Scale, -0.61 for the Euroqol, and -0.60 for a visual analogue scale evaluating Quality-of-Life. The summary index revealed a significant increase with increasing disease severity. The SCOPA-PS is a new, short psychosocial questionnaire for patients with PD with good clinimetric properties.

摘要

本研究的目的是开发一份针对帕金森病(PD)患者心理社会功能的简短问卷。帕金森病心理社会问卷量表(SCOPA - PS)在一项调查中进行了测试,并与其他工具以及医学信息进行了比较。该调查问卷被发送给205名特发性PD患者。86%的问卷被收回。克朗巴哈系数为0.83。两周重测信度为0.85(组内相关系数)。与其他量表的结构效度(斯皮尔曼等级相关系数)方面,帕金森病问卷39项版本(PDQ - 39)为0.82,PDQ - 8为0.76,医院焦虑抑郁量表为0.69,欧洲五维度健康量表为 - 0.61,评估生活质量的视觉模拟量表为 - 0.60。汇总指数显示随着疾病严重程度增加有显著升高。SCOPA - PS是一份针对PD患者的新的简短心理社会问卷,具有良好的临床测量学特性。

相似文献

1
A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS.一份针对帕金森病患者的简短社会心理调查问卷:SCOPA-PS。
J Clin Epidemiol. 2003 Jan;56(1):61-7. doi: 10.1016/s0895-4356(02)00569-3.
2
Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study.使用SCOPA-PS评估接受DBS-STN治疗的法国帕金森病患者的健康相关生活质量:一项验证研究。
Rev Neurol (Paris). 2016 Apr-May;172(4-5):281-8. doi: 10.1016/j.neurol.2015.10.010. Epub 2016 May 2.
3
Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.SCOPA-心理社会量表及巴西版PDQ-39的度量特性的独立验证
Mov Disord. 2007 Jan;22(1):91-8. doi: 10.1002/mds.21216.
4
Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries.在四个拉丁美洲国家中对帕金森病心理社会结局量表(SCOPA-PS)进行跨文化验证。
Value Health. 2009 Mar-Apr;12(2):385-91. doi: 10.1111/j.1524-4733.2008.00436.x. Epub 2008 Jul 24.
5
[Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].[帕金森病心理社会结局量表(SCOPA-PS)的心理测量属性:西班牙的验证及综述]
Rev Neurol. 2009;49(1):1-7.
6
Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.焦虑与抑郁:巴西帕金森病患者健康相关生活质量的主要决定因素。
Parkinsonism Relat Disord. 2008;14(2):102-8. doi: 10.1016/j.parkreldis.2007.06.011. Epub 2007 Aug 24.
7
Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC.帕金森病精神并发症的评估:SCOPA-PC量表
Mov Disord. 2007 Nov 15;22(15):2221-8. doi: 10.1002/mds.21696.
8
Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease.帕金森病患者医院焦虑抑郁量表的评估
Clin Neuropharmacol. 2002 Nov-Dec;25(6):318-24. doi: 10.1097/00002826-200211000-00008.
9
Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.帕金森病睡眠结局量表(韩文版)的验证。
J Korean Med Sci. 2018 Jan 8;33(2):e14. doi: 10.3346/jkms.2018.33.e14.
10
Validation of the Bulgarian version of Scales for Outcomes in Parkinson's Disease - Autonomic (SCOPA-AUT-BG).帕金森病自主神经功能障碍量表保加利亚语版(SCOPA-AUT-BG)的验证
Folia Med (Plovdiv). 2013 Jul-Dec;55(3-4):56-62. doi: 10.2478/folmed-2013-0028.

引用本文的文献

1
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.唐氏综合征巴塞罗那神经影像倡议组织(DABNI)及其对理解唐氏综合征中的阿尔茨海默病的贡献:十年探索成果
Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.
2
Psycho-physical interactions in Parkinson's Disease: Protocol for a prospective observational cohort study.帕金森病中的心理-生理相互作用:一项前瞻性观察队列研究方案
PLoS One. 2024 Dec 16;19(12):e0315345. doi: 10.1371/journal.pone.0315345. eCollection 2024.
3
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review.
帕金森病、进行性核上性麻痹和多系统萎缩中与健康相关生活质量评估量表的系统评价
Front Psychol. 2024 Sep 10;15:1438830. doi: 10.3389/fpsyg.2024.1438830. eCollection 2024.
4
Understanding Psychosocial Functioning, Caregiver Burden, and Neuropalliative Care in Parkinson's Disease - A Mixed-Methods Study.理解帕金森病中的心理社会功能、照顾者负担和神经姑息治疗——一项混合方法研究
Ann Indian Acad Neurol. 2024 May 1;27(3):289-296. doi: 10.4103/aian.aian_83_24. Epub 2024 Jun 21.
5
Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.帕金森病患者的健康相关生活质量:EuroQol (EQ-5D) 效用评分的系统评价和荟萃分析。
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
6
Association between fatigue and MDS-UPDRS in individuals with Parkinson's disease: cross-sectional study.帕金森病患者的疲劳与 MDS-UPDRS 之间的关联:横断面研究。
Neurol Sci. 2024 Sep;45(9):4309-4321. doi: 10.1007/s10072-024-07466-z. Epub 2024 Mar 26.
7
Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium.共病神经创伤增加快速眼动睡眠行为障碍患者与神经退行性变相关的认知、运动和自主神经功能障碍:北美前驱神经核蛋白病联盟的子研究。
Sleep. 2024 Jun 13;47(6). doi: 10.1093/sleep/zsae007.
8
The Effect of Different Types of Exercise on Sleep Quality and Architecture in Parkinson Disease: A Single-Blinded Randomized Clinical Trial Protocol.不同类型运动对帕金森病睡眠质量和结构的影响:一项单盲随机临床试验方案。
Phys Ther. 2024 Jan 1;104(1). doi: 10.1093/ptj/pzad073.
9
Baseline characteristics of the North American prodromal Synucleinopathy cohort.北美前驱性神经核蛋白病队列的基线特征。
Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8.
10
Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease.帕金森病短期多学科日间门诊治疗后的运动和非运动改善。
J Neural Transm (Vienna). 2022 Dec;129(12):1419-1426. doi: 10.1007/s00702-022-02562-w. Epub 2022 Nov 6.